Eli Lilly in the NEWS
INDIANAPOLIS, April 1, 2026 /PRNewswire/, Eli Lilly and Company (LLY), announced the U.S. FDA approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced-calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available via LillyDirect®, with . . .
This content is for paid subscribers.
Impacting News
April 2, 2026
, the Only GLP-1 Pill for Weight Loss That Can Be Taken Any Time of Day Without Food or Water Restrictions){kind=link}